Meeting
2022 ASCO Annual Meeting
Impact of germline mutations on surgical decision-making in women with DCIS.
Authors
Rachel E Ellsworth
Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences,, Windber, PA
Rachel E Ellsworth , Lauren Turza , Leann A Lovejoy , Clesson E Turner , Craig D Shriver
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10576)
DOI
10.1200/JCO.2022.40.16_suppl.10576
Abstract #
10576
Poster Bd #
451
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Variant of uncertain significance (VUS) genetic testing results and mastectomy choice in lumpectomy-eligible patients.
First Author: Osvaldo Nunez Jr. Jr.
Poster
2023 ASCO Annual Meeting
Twenty-one gene recurrence scores in individuals with breast cancer associated with CHEK2 and ATM germline pathogenic variants.
First Author: Payal Deepak Shah
Poster
2023 ASCO Annual Meeting
Characteristics and clinical outcome of BRCA germline mutation carriers with advanced breast cancer treated with PARP (poly ADP-ribose polymerase) inhibitors: A single institution experience.
First Author: Fatma Nihan Akkoc Mustafayev
Poster
2022 ASCO Annual Meeting
Detection of early-stage breast cancer in women by plasma lipidomic profiling.
First Author: Cheka Kehelpannala